NDC 69097-385 – lenalidomide
Lenalidomide 25 mg/1 · Capsule · Oral
Product NDC69097-385
Product details
- Brand name
- lenalidomide
- Generic name
- lenalidomide
- Labeler
- Cipla USA Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA210435
- Marketed since
- September 6, 2022
- Listing expires
- December 31, 2026
- Pharmacologic class
- Thalidomide Analog
Active ingredients
- Lenalidomide 25 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69097-385-81 | 21 CAPSULE in 1 BOTTLE, PLASTIC (69097-385-81) | Sep 6, 2022 |
Other Lenalidomide products
- 16729-695 Lenalidomide 15 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-697 Lenalidomide 25 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-693 Lenalidomide 5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-696 Lenalidomide 20 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-692 Lenalidomide 2.5 mg/1 · Capsule · Accord Healthcare Inc.
- 16729-694 Lenalidomide 10 mg/1 · Capsule · Accord Healthcare Inc.
- 47781-486 Lenalidomide 15 mg/1 · Capsule · Alvogen, Inc.
- 47781-488 Lenalidomide 25 mg/1 · Capsule · Alvogen, Inc.
- 47781-484 Lenalidomide 5 mg/1 · Capsule · Alvogen, Inc.
- 47781-483 Lenalidomide 2.5 mg/1 · Capsule · Alvogen, Inc.
- 47781-487 Lenalidomide 20 mg/1 · Capsule · Alvogen, Inc.
- 47781-485 Lenalidomide 10 mg/1 · Capsule · Alvogen, Inc.